Eric K Rowinsky Insider Trading $NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eric K Rowinsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eric K Rowinsky. Eric K Rowinsky is Chief Medical Officer in IMCLONE SYSTEMS INC ($IMCLE) and SVP, CHIEF MEDICAL OFFICER in IMCLONE SYSTEMS INC ($IMCLE) and Director in BIOGEN INC. ($IDPH) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Chief Medical Officer in STEMLINE THERAPEUTICS INC ($STML) and Director in BIND Therapeutics, Inc ($BIND) and Director in Fortress Biotech, Inc. ($FBIO) and Director in Verastem, Inc. ($VSTM).
Eric K Rowinsky in NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Eric K Rowinsky: Director
Holdings: 341,446 shares
Current Value: $177,552
Latest Transaction: Feb 22 2018
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Eric K Rowinsky in NAVIDEA BIOPHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, BIND, FBIO, IMCLE, NAVB, STML, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2018 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 173,764 | |
| Feb 22 2018 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 50 | 341,446 | 291.4 K to 341.4 K (+17.16 %) |
| Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
| Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 50 | 291,446 | 241.4 K to 291.4 K (+20.71 %) |
| Apr 29 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 28,000 | 0 | 224,446 | 196.4 K to 224.4 K (+14.25 %) |
| Apr 29 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 1.14 | 10,726 | 12,228 | 196,446 | 185.7 K to 196.4 K (+5.78 %) |
| Mar 30 2015 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 22,000 | 0 | 185,720 | 163.7 K to 185.7 K (+13.44 %) |
Page: 1